Newly reassembled after being moved from  Pittsburgh, the smaller, more automated press also prints the New York Times, Wall ...

Physicists in Germany have carried out the most accurate measurement to date of the width of the proton. By examining a previously unexplored energy-level transition in the hydrogen atom, Lothar ...

What’s the difference between pairs figure skating and ice dancing at the 2026 Winter Olympics? Here’s how the Olympic disciplines compare.

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...

CATL 5C battery promises 12-minute charging and million-mile durability. Here's what the data shows, how it works, and what's next for EVs!!

NEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min St. Louis is moving ahead with ...

Yale School of Medicine (YSM) scientists have discovered a molecular difference in the brains of autistic people compared to their neurotypical counterparts. Autism is a neurodevelopmental condition ...

Right now, the debate about consciousness often feels frozen between two entrenched positions. On one side sits computational functionalism, which treats cognition as something you can fully explain ...

Kalaris Therapeutics offers a differentiated approach to neovascular AMD with its lead candidate TH103, leveraging unique molecular engineering for improved efficacy and durability. KLRS's Phase 1a ...

So hi, everyone. Welcome to today's webinar with PPMD, where we're joined by Capricor Therapeutics, who are providing a community update on their Phase 3 trial, HOPE-3, which was evaluating their ...